EGFR-IN-171 is an EGFR inhibitor with an IC50 value of 0.19 µM. EGFR-IN-171 also inhibits vascular endothelial growth factor 2 (VEGFR-2) with an IC50 value of 31.65 µM. EGFR-IN-171 can induce apoptosis and G2/M phase cell cycle arrest. EGFR-IN-171 can be used for cancer research, such as liver and breast cancer[1].
Molecular Weight:
546.64
Formula:
C32H26N4O3S
Target:
Apoptosis,Bcl-2 Family,EGFR,MDM-2/p53
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
